Discontinuation report MENOMUNE-A/C/Y/W-135

Last updated on 2017-03-29 History
Report ID 4473
Drug Identification Number 00588490
Brand name MENOMUNE-A/C/Y/W-135
Common or Proper name Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined
Company Name SANOFI PASTEUR LIMITED
Active Ingredient(s) MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
Strength(s) 500MCG 500MCG 500MCG 500MCG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1 x 0.5 mL vial plus 1 x 0.6 mL diluent / 1 flacon de 1 dose de 0,5 mL et 1 flacon de 0,6 mL de diluant
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-03-28
Actual discontinuation date 2017-03-28
Remaining supply date 2017-03-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply There is currently no remaining supply.
Company comments Sanofi Pasteur has decided to discontinue the global supply production and commercialization of MENOMUNE®, its polysaccharide meningococcal vaccine.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-03-29 French Compare
v5 2017-03-29 English Compare
v4 2017-03-28 French Compare
v3 2017-03-28 English Compare
v2 2017-03-28 French Compare
v1 2017-03-28 English Compare